Omeros, Daiichi Sankyo deal

Daiichi Sankyo's Asubio Pharma Co. Ltd. subsidiary granted Omeros an exclusive, worldwide license to undisclosed preclinical compounds for use in Omeros' phosphodiesterase-7 (PDE-7) program. Asubio w...